NSCI Stock Overview
Develops, manufactures, and sells magnetic resonance technology products in Canada, the United States, Canada, Europe, Asia, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 3/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Nanalysis Scientific Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.31 |
| 52 Week High | CA$0.60 |
| 52 Week Low | CA$0.25 |
| Beta | 0.65 |
| 1 Month Change | -15.07% |
| 3 Month Change | -18.42% |
| 1 Year Change | -17.33% |
| 3 Year Change | -77.86% |
| 5 Year Change | -35.42% |
| Change since IPO | -43.64% |
Recent News & Updates
The Market Doesn't Like What It Sees From Nanalysis Scientific Corp.'s (CVE:NSCI) Revenues Yet As Shares Tumble 25%
Dec 14
Is Nanalysis Scientific (CVE:NSCI) Using Too Much Debt?
Oct 28Recent updates
The Market Doesn't Like What It Sees From Nanalysis Scientific Corp.'s (CVE:NSCI) Revenues Yet As Shares Tumble 25%
Dec 14Is Nanalysis Scientific (CVE:NSCI) Using Too Much Debt?
Oct 28Nanalysis Scientific Corp.'s (CVE:NSCI) CEO Will Probably Find It Hard To See A Huge Raise This Year
Jun 19Nanalysis Scientific Corp. (CVE:NSCI) Stock Catapults 29% Though Its Price And Business Still Lag The Industry
May 12Benign Growth For Nanalysis Scientific Corp. (CVE:NSCI) Underpins Stock's 25% Plummet
Mar 24Nanalysis Scientific Corp. (CVE:NSCI) Shares Fly 43% But Investors Aren't Buying For Growth
Feb 08We Think Nanalysis Scientific (CVE:NSCI) Has A Fair Chunk Of Debt
Jan 31Would Nanalysis Scientific (CVE:NSCI) Be Better Off With Less Debt?
Aug 26Nanalysis Scientific Corp.'s (CVE:NSCI) Price Is Right But Growth Is Lacking
Apr 17Is Nanalysis Scientific (CVE:NSCI) Using Too Much Debt?
Dec 08Is Nanalysis Scientific (CVE:NSCI) Weighed On By Its Debt Load?
Jul 15Health Check: How Prudently Does Nanalysis Scientific (CVE:NSCI) Use Debt?
Jan 24Is Nanalysis Scientific (CVE:NSCI) Using Debt Sensibly?
Mar 29Nanalysis Scientific (CVE:NSCI) Has Debt But No Earnings; Should You Worry?
Dec 14
Shareholder Returns
| NSCI | CA Medical Equipment | CA Market | |
|---|---|---|---|
| 7D | 19.2% | -5.0% | -2.0% |
| 1Y | -17.3% | -18.4% | 15.2% |
Return vs Industry: NSCI exceeded the Canadian Medical Equipment industry which returned -18.4% over the past year.
Return vs Market: NSCI underperformed the Canadian Market which returned 15.2% over the past year.
Price Volatility
| NSCI volatility | |
|---|---|
| NSCI Average Weekly Movement | 8.2% |
| Medical Equipment Industry Average Movement | 13.7% |
| Market Average Movement | 8.2% |
| 10% most volatile stocks in CA Market | 17.4% |
| 10% least volatile stocks in CA Market | 2.9% |
Stable Share Price: NSCI has not had significant price volatility in the past 3 months compared to the Canadian market.
Volatility Over Time: NSCI's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 249 | Sean Krakiwsky | www.nanalysis.com |
Nanalysis Scientific Corp. develops, manufactures, and sells magnetic resonance technology products in Canada, the United States, Canada, Europe, Asia, and internationally. The company operates through Scientific Equipment and Security Services segment. It offers nuclear magnetic resonance (NMR) spectrometers; magnetic resonance test, and measurement and diagnostic system; 60 MHz and 100 MHz NMR platform; and Cameleon 4 console, a compact alternative to facilitate MRI for teaching.
Nanalysis Scientific Corp. Fundamentals Summary
| NSCI fundamental statistics | |
|---|---|
| Market cap | CA$35.06m |
| Earnings (TTM) | -CA$8.28m |
| Revenue (TTM) | CA$43.01m |
0.8x
P/S Ratio-4.2x
P/E RatioIs NSCI overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| NSCI income statement (TTM) | |
|---|---|
| Revenue | CA$43.01m |
| Cost of Revenue | CA$32.73m |
| Gross Profit | CA$10.28m |
| Other Expenses | CA$18.56m |
| Earnings | -CA$8.28m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.073 |
| Gross Margin | 23.90% |
| Net Profit Margin | -19.26% |
| Debt/Equity Ratio | 67.7% |
How did NSCI perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/23 23:38 |
| End of Day Share Price | 2024/12/23 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Nanalysis Scientific Corp. is covered by 2 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Douglas Loe | Leede Jones Gable Inc |
| Stefan Quenneville | Ventum Financial Corp |